HKU Scholars Hub: Browsing DSpace

Browsing by Author Blanc, JF

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 6 of 6

	Title	Author(s)	Issue Date
	Comparative Efficacy of Cabozantinib and Regorafenib for Advanced Hepatocellular Carcinoma Journal:Advances in Therapy	Kelley, RK Mollon, P Blanc, JF Daniele, B Yau, T Cheng, AL Valcheva, V Marteau, F Guerra, I Abou-Alfa, GK	2020
	Pharmacodynamic biomarkers predictive of survival benefit with lenvatinib in unresectable hepatocellular carcinoma: from the phase III REFLECT study Journal:Clinical Cancer Research	Finn, RS Kudo, M Cheng, AL Wyrwicz, L Ngan, RKC Blanc, JF Baron, AD Vogel, A Ikeda, M Piscaglia, F Han, KH Qin, S Minoshima, Y Kanekiyo, M Ren, M Dairiki, R Tamai, T Dutcus, CE Ikezawa, H Funahashi, Y Evans, TRJ	2021
	Phase II Studies with Refametinib or Refametinib plus Sorafenib in Patients with RAS-Mutated Hepatocellular Carcinoma Journal:Clinical Cancer Research	Lim, HY Merle, P Weiss, KH Yau, TCC Ross, P Mazzaferro, V Blanc, JF Ma, YT Yen, CJ Kocsis, J Choo, SP Sukeepaisarnjaroen, W Gérolami, R Dufour, JF Gane, EJ Ryoo, BY Peck-Radosavljevic, M Dao, T Yeo, W Lamlertthon, W Thongsawat, S Teufel, M Roth, K Reis, D Childs, BH Krissel, H Llovet, JM	2018
	Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH study Journal:European Journal of Cancer	Chau, I Peck-Radosavljevic, M Borg, C Malfertheiner, P Seitz, JF Park, JO Ryoo, BY Yen, CJ Kudo, M Poon, RTP Pastorelli, D Blanc, JF Chung, HC Baron, AD Okusaka, T Bowman, L Cui, ZL Girvan, AC Abada, PB Yang, L Zhu, AX	2017
	A randomized, double-blind, multicenter phase 3 study of brivanib versus placebo as adjuvant therapy to trans-arterial chemoembolization in patients with unresectable hepatocellular carcinoma: initial results Proceeding/Conference:Annual Conference of the International Liver Cancer Association, ILCA 2013	Kudo, M Finn, R Poon, RTP Blanc, JF Han, G Yan, L Yang, J Lu, L Tak, WY XU, X Lee, JH Lin, SM Wu, C Tanwandee, T Shao, G Walters, L Dela Cruz, C Poulart, V Wang, JH	2013
	Serum alpha-fetoprotein levels and clinical outcome in the phase 3 CELESTIAL study of cabozantinib versus placebo in patients with advanced hepatocellular carcinoma Journal:Clinical Cancer Research	Kelley, RK Meyer, T Rimassa, L Merle, P Park, JW Yau, T Chan, SL Blanc, JF Tam, VC Tran, A Dadduzio, V Markby, DW Kaldate, R Cheng, AL El-Khoueiry, AB Abou-Alfa, GK	2020

Showing results 1 to 6 of 6